ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
ExtraPace
|
943 |
335K |
2 |
15:20 |
15:20 |
ASX - By Stock
|
943
|
335K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
ExtraPace
|
943 |
335K |
2 |
14:31 |
14:31 |
ASX - By Stock
|
943
|
335K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
108 |
21K |
16 |
11:27 |
11:27 |
ASX - By Stock
|
108
|
21K
|
16
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ExtraPace
|
124 |
48K |
28 |
10:52 |
10:52 |
ASX - By Stock
|
124
|
48K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
108 |
21K |
26 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
108
|
21K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
108 |
21K |
16 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
108
|
21K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
ExtraPace
|
108 |
21K |
30 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
108
|
21K
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
7 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
24K
|
11M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
10 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
24K
|
11M
|
10
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ExtraPace
|
124 |
48K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
124
|
48K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
24K
|
11M
|
7
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Change in substantial holding
|
|
ExtraPace
|
5 |
2.3K |
13 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
5
|
2.3K
|
13
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
ExtraPace
|
124 |
48K |
10 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
124
|
48K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
ExtraPace
|
14K |
6.6M |
9 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
14K
|
6.6M
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
18 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
495
|
112K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to Bell Potter Conference
|
|
ExtraPace
|
159 |
68K |
23 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
159
|
68K
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
17 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
495
|
112K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
21 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
495
|
112K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
20 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
495
|
112K
|
20
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
555K |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.4K
|
555K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ExtraPace
|
152 |
57K |
17 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
152
|
57K
|
17
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ExtraPace
|
152 |
57K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
152
|
57K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
13 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
24K
|
11M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
10 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
24K
|
11M
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
35 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
495
|
112K
|
35
|
|
ASX - By Stock
|
SYR Lithium |
Re:
SYR Charts
|
|
ExtraPace
|
3.3K |
1.5M |
7 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
3.3K
|
1.5M
|
7
|
|
ASX - By Stock
|
SYR Lithium |
Re:
SYR Charts
|
|
ExtraPace
|
3.3K |
1.5M |
3 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
3.3K
|
1.5M
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Pharmaust Investor Update
|
|
ExtraPace
|
20 |
5.5K |
25 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
20
|
5.5K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
23 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
24K
|
11M
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
16 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
495
|
112K
|
16
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
ExtraPace
|
152 |
57K |
22 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
152
|
57K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
23 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
495
|
112K
|
23
|
|
ASX - By Stock
|
SYR |
Re:
Ann: Managing Director's AGM Presentation
|
|
ExtraPace
|
10 |
4.3K |
19 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
10
|
4.3K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ExtraPace
|
24K |
11M |
5 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
24K
|
11M
|
5
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
555K |
16 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
1.4K
|
555K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
12 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
495
|
112K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
14 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
495
|
112K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
6 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
495
|
112K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
16 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
495
|
112K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
20 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
495
|
112K
|
20
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
ExtraPace
|
943 |
335K |
0 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
943
|
335K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
ExtraPace
|
86 |
20K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
4
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
555K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
1.4K
|
555K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
ExtraPace
|
495 |
112K |
12 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
495
|
112K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
ExtraPace
|
222 |
47K |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
222
|
47K
|
4
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
555K |
0 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
555K
|
0
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
ExtraPace
|
1.4K |
555K |
10 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
555K
|
10
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
ExtraPace
|
8.1K |
3.2M |
5 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
8.1K
|
3.2M
|
5
|
|
ASX - By Stock
|
WBT |
Re:
WBT Chart
|
|
ExtraPace
|
68 |
28K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
68
|
28K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification regarding unquoted securities - DXB
|
|
ExtraPace
|
12 |
6.0K |
5 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
12
|
6.0K
|
5
|
|